The AcrySof® ReSTOR® IOL (intraocular lens) gives people the ability to see near, far or in between, often freeing people from the need for glasses. Cataracts aren’t uncommon; they’re a natural part of the aging process for many people. Previous IOLs used to replace cataracts were either limited to middle-vision or monovision, meaning a person could only see in the middle ranges or had to have one eye focused for near and the other for distance vision.
The ReSTOR® lens is revolutionary because it is a permanent lens that provides for the full range of vision with little or no need for glasses or other corrective lenses. After anesthetic eye drops have been applied to the eye, the surgeon makes a small incision. An instrument is then used to dissolve the clouded lens and the ReSTOR® lens is inserted. Because no stitches are used and the eye heals itself, the procedure is virtually pain-free and recovery is fast.
This lens is revolutionary because it allows for all-distance vision. It is tapered from the center to the outside to allow a smooth transition of light, be it from near, far or in-between focal points. After surgery, four out of five patients reported never wearing glasses. And 94% were so satisfied that they’d do it all again. So call Mann Eye Institute today to set up a free consultation or click here to schedule online!
New Medicare Policy Allows Seniors Access to Crystalens and ReSTOR® Advanced Lens Technology at Mann Eye Institute!
Seniors on Medicare now can choose the presbyopia-correcting Crystalens® and ReSTOR® lenses, which treat two conditions: cataract removal with lens replacement (a procedure covered by Medicare) and presbyopia (a non-covered service). Patients who select Crystalens® or ReSTOR® will receive the standard Medicare reimbursement for cataract surgery, and can now pay privately for the presbyopic portion of their treatment.
Presbyopia is an inevitable age-related eye condition that makes it difficult to read or see objects up-close without the use of reading glasses. Presbyopia is the first sign of cataracts and is the most prevalent eye condition in America. It causes the crystalline lens to increasingly stiffen, lose flexibility and cloud, diminishing its focusing ability.
“This policy change means that patients now have the right to choose a vision correction technology that can improve their reading vision and best meets their visual demands. It also gives us the ability to offer innovative technologies for improving both vision and lifestyle for our Medicare patients,” says Dr. Mike Mann.
To find out if you’re a candidate for ReSTOR® or Crystalens®, call our office today for your free consultation at 1(800) MY-VISION!